Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Islet replacement vs. regeneration: hope or hype?

Vijayakumar Ramiya1, Desmond Schatz

  • 1Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA. ramiyvk@peds.ufl.edu

Pediatric Diabetes
|December 17, 2004
PubMed
Summary

Type 1 diabetes management is costly and challenging. Stem cell therapies and islet regeneration offer promising future treatments for restoring pancreatic beta-cell function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune Intervention and Beta Cell Replacement Therapies in T1D.

Diabetes technology & therapeutics·2026
Same author

Association of fever and infections with the subsequent risk of atopic diseases in children with genetic susceptibility for T1D: Results from the TEDDY cohort study.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

Heterogeneous effects of sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors on nephrolithiasis in older adults with type 2 diabetes.

Pharmacotherapy·2025
Same author

Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) Study.

Diabetes care·2025
Same author

Immune Intervention and Replacement Therapies in Type 1 Diabetes.

Diabetes technology & therapeutics·2025
Same author

Comment on Lombardo et al. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. <i>Children</i> 2022, <i>9</i>, 1087.

Children (Basel, Switzerland)·2025

Area of Science:

  • Endocrinology and Metabolism
  • Immunology
  • Regenerative Medicine

Background:

  • Type 1 diabetes results from autoimmune destruction of pancreatic islet beta-cells.
  • Current management is burdensome, with high societal costs and challenges like tissue shortage and lifelong immunosuppression.
  • Existing treatments face hurdles in widespread application due to these limitations.

Purpose of the Study:

  • To explore the potential of stem cells for pancreatic beta-cell replacement.
  • To investigate strategies for in vivo stem cell differentiation into functional islets.
  • To examine the possibility of endogenous islet regeneration through autoimmunity modulation and growth factor supplementation.

Main Methods:

  • Review of current stem cell research (embryonic and adult) for beta-cell development.
  • Discussion of in vivo differentiation approaches to minimize in vitro manipulation.
  • Exploration of therapeutic strategies targeting autoimmunity and promoting beta-cell replication/neogenesis.

Main Results:

  • Stem cells represent a promising avenue for addressing pancreatic islet shortage.
  • In vivo stem cell development into islets is crucial for clinical applicability.
  • Islet regeneration by down-regulating autoimmunity and supplementing with specific factors is a viable research direction.

Conclusions:

  • Stem cell-based therapies are still in preliminary stages but hold significant future potential.
  • In vivo stem cell differentiation and endogenous islet regeneration are key areas for future research.
  • Islet regeneration research is poised to gain prominence, complementing stem cell approaches for Type 1 diabetes treatment.

Related Experiment Videos